Report Scope:
This report represents a current and important business tool to evaluate terms and conditions of licensing, acquisitions and partnerships deals in the biomarker sector. The geographic scope of this study covers the U. S. and companies worldwide. The report identifies the main elements in licensing, acquisitions and partnership deals in the biomarker industry.
Report Includes:
- 43 data tables and 42 additional tables
- An overview of the current state of the biomarker industry, recent licensing deals, and collaborations and acquisitions in the market, including detailed analysis of deals structure and their potential values
- Information about significant players in this field of study, trends and obstacles, and other information affecting biomarker market development
- Review of business terms and conditions of deals in the biomarker market, with focus on major trends in biomarker deal making, the companies involved and analysis of further potential in out-licensing, collaboration and acquisition opportunities
- Essential information to a prospective dealmaker about partnering in the research, development and commercialization of biomarker technologies and products.
- Identification of the main elements in licensing, acquisitions and partnership deals in the biomarker industry
- Coverage of research methodology employing a triangulating approach and significant details of patent search and analysis, clinical trial search and analysis et al.
- Details of various types of biomarkers deals and milestone payments and their value in different deals
- Examination of competitive landscape and detailed profiles of major companies developing biomarkers, including bioMérieux SA, IntegraGen SA, MDxHealth, Myriad Genetics, Protagen AG and Qiagen
Biomarker Deals: Terms, Value and Trends, 2008-2018
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources and Methodology
Intended Audience
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Biomarker Definition and Classification
Biomarker Applications
Biomarker Identification and Detection Technologies
Steps in Biomarker Development
Biomarker Market Analysis and Evaluation
Global Biomarker Market Value and its Segmentation
Oncology-Related Biomarkers Sector
Cardiovascular Diseases Biomarker Sector
Neurological Disorders and Other Diseases Biomarkers Sector
Market Participants in the Biomarkers Space
Chapter 4 Biomarkers Market - Licensing, Acquisitions, Collaborations Deal Analysis
Licensing Deals in the Biomarkers Market, 2008-2018
Licensing Deal Definition and General Structure
Valuation and Payment Structure
Analysis of Licensing Deals in the Biomarkers Market, 2008-2018
Acquisition Deals in the Biomarkers Market, 2008-2018
Acquisition Deal Definition and General Structure
Analysis of Acquisition Deals in the Biomarkers Market, 2008-2018
Partnerships/Collaboration Deals in the Biomarkers Market, 2008-2018
Collaboration Deal Definition and General Structure
Analysis of Partnership/collaboration Deals in the Biomarkers Market, 2008-2018
Analysis of Different Aspects of Licensing, Acquisition and Collaboration Deals in the Biomarkers Market
Analysis of Licensing Deals Structure in the Biomarkers Market, 2008-2018
Analysis of Acquisition Deals Structure in the Biomarkers Market, 2008-2018
Analysis of Collaboration Deals Structure in the Biomarkers Market, 2008-2018
Biomarker Market Participants Active in Licensing, Acquisitions and Partnership/Collaboration Deals, 2008-2018
Qiagen
bioMerieux
MDxHealth
Myriad Genetics
Chapter 5 Impact of Other Markets and Clinical Trials on Licensing, Acquisition and Collaborations in the Biomarkers Market
Cancer Diagnostics as Market Potential for Exosome-Based Diagnostics Product Development
Prostate Cancer as Potential for Biomarker Development
Breast Cancer as Potential for Biomarker Development
Bladder Cancer as Potential for Biomarker Development
Ovarian Cancer as Potential for Biomarker Development
Lung Cancer as Potential for Biomarker Development
CNS Disorders and Neurodegeneration Diseases as Market Potential for Biomarker Development
Cardiovascular Diseases as Market Potential for Biomarker Development
Organ Transplantation as Market Potential for Biomarker Development in Immune Disorders
Clinical Trials as Indicator for Biomarker Market Development
Chapter 6 Patent Review/New Developments
Chapter 7 Market Summary
Chapter 8 Company Profiles
BIOMERIEUX S.A.
INTEGRAGEN SA
MDX HEALTH
MYRIAD GENETICS
PROTAGEN AG
QIAGEN
List of Tables
Summary Table : Global Biomarkers Licensing, Acquisition and Partnership Deals Market, by Type, 2014-2018
Table 1 : Biomarker Classification
Table 2 : Applications of Biomarkers
Table 3 : Common Techniques Used for Biomarker Identification
Table 4 : Global Biomarkers Market, Through 2023
Table 5 : Global Biomarker Market Share, by Application, 2018
Table 6 : Examples of Cancer Biomarkers for Therapy Selection and Monitoring
Table 7 : Examples of Current Cancer-Associated Antigens/Biomarkers Used in Cancer Diagnosis
Table 8 : Liquid Biopsy Market, 2017 and 2018
Table 9 : Global Cancer Biomarkers Market, Through 2023
Table 10 : Examples of Cardiovascular Biomarkers Used for Clinical Diagnosis
Table 11 : Global Cardiovascular Biomarkers Market, Through 2023
Table 12 : Examples of Neurological Biomarkers for Clinical Diagnosis
Table 13 : Global Biomarkers Market, by Application Sector, Through 2023
Table 14 : Examples of Biomarkers Market Participants
Table 15 : Overview of Common Payment Forms in Licensing Deal
Table 16 : Number of Biomarker Licensing Deals in Different Biotech Sectors, 2008-2018
Table 17 : Share of Biomarker Licensing Deals in Different Biotech Sectors, by Year, 2008-2018
Table 18 : Example of Licensing Deals, 2008-2018
Table 19 : Number of Biomarker Licensing Deals in Different Pathological Sectors, 2008-2018
Table 20 : Share of Biomarker Licensing Deals in Different Pathological Sectors, 2008-2018
Table 21 : Purpose of Biomarker Licensing Deals, 2008-2018
Table 22 : Share of Licensing Deals Between Companies and Academic Institutions vs. Between Two Companies, 2008-2018
Table 23 : Share of Biomarker Licensing Deals in North America vs. Europe, 2008-2018
Table 24 : Total Number of Biomarker Acquisition Deals in Different Biotech Sectors, 2008-2018
Table 25 : Share of Biomarker Acquisition Deals in Different Biotech Sectors, by Year, 2008-2018
Table 26 : Examples of Acquisition Deals, 2008-2018
Table 27 : Number of Biomarker Acquisition Deals in Different Pathological Sectors, 2008-2018
Table 28 : Share of Biomarker Acquisition Deals in Different Pathological Sectors, 2008-2018
Table 29 : Purpose of Biomarkers Acquisition Deals, 2008-2018
Table 30 : Share of Biomarker Acquisition Deals in North America Vs. Europe, 2008-2018
Table 31 : Total Number of Biomarker Collaboration Deals in Different Biotech Sectors, 2008-2018
Table 32 : Share of Biomarker Collaboration Deals in Different Biotech Sectors, by Year, 2008-2018
Table 33 : Examples of Partnership/Collaboration Deals in the Biomarkers Market, 2008-2018
Table 34 : Number of Biomarker Collaboration Deals in Different Pathological Sectors, 2008-2018
Table 35 : Share of Biomarker Collaboration Deals in Different Pathological Sectors, 2008-2018
Table 36 : Purpose of Biomarkers Collaboration Deals, 2008-2018
Table 37 : Share of Collaboration Deals Between Companies and Academic Institutions vs. Between Two Companies, 2008-2018
Table 38 : Share of Biomarker Collaborations/Partnerships in North America vs. Europe, 2008-2018
Table 39 : Examples of Upfront Payments in Licensing Deals, 2008-2018
Table 40 : Examples of Milestone and Royalty Payments in Licensing Deals, 2008-2018
Table 41 : Examples of Termination Condition in Licensing Biomarkers Deals, 2008-2018
Table 42 : Global Biomarkers Licensing Deals Market, 2014-2018
Table 43 : Examples of Acquisition Deals Values in the Biomarkers Market, 2008-2018
Table 44 : Global Value of Biomarkers Acquisition Deals, 2014-2018
Table 45 : Examples of Upfront Payments and Total Value in Collaboration Deals, 2008-2018
Table 46 : Share of Upfront Payments from Total Value in Collaboration Deals, 2008-2018
Table 47 : Examples of Milestones and Royalty Payments in Collaboration Deals, 2008-2018
Table 48 : Examples of Termination Conditions in Collaboration Biomarkers Deals, 2008-2018
Table 49 : Global Value of Biomarkers Partnership Deals, 2014-2018
Table 50 : Examples of Biomarker Market Participants in Licensing, Collaboration and Acquisition Deals, 2008-2018
Table 51 : Examples of Biomarker Market Participants and Total Number of Deals Related to Biomarker Activity, 2008-2018
Table 52 : Financial Data for Qiagen, 2015-2017
Table 53 : Financial Data for bioMérieux, 2015-2017
Table 54 : Financial Data for MDxHealth, 2015-2017
Table 55 : Financial Data for Myriad Genetics, 2015-2017
Table 56 : Statistics for Prostate Cancer, 2017
Table 57 : Global Prostate Cancer Diagnostics Market and Related Cost, 2018-2023
Table 58 : Statistics for Breast Cancer, 2017
Table 59 : Global Market for Breast Cancer Diagnostics, Through 2019
Table 60 : Statistics for Bladder Cancer, 2017
Table 61 : Global Market for Bladder Cancer Diagnostics, 2017
Table 62 : Statistics for Ovarian Cancer, 2017
Table 63 : Global Ovarian Cancer Diagnostics Market, 2017
Table 64 : Statistics for Lung Cancer, 2017
Table 65 : Global Lung Cancer Diagnostics Market, 2017
Table 66 : U.S. Statistics Data for Alzheimer's, 2017
Table 67 : Global Market for Alzheimer's Disease Therapeutics and Diagnostics, Through 2020
Table 68 : U.S. Statistics Data for Cardiovascular Diseases, 2017
Table 69 : Global Cardiovascular Diagnostics Market, 2017
Table 70 : Global Organ and Tissue Transplantation Products and Devices Market, Through 2020
Table 71 : Number of Clinical Trials on Biomarkers Per Year, 2008-2017
Table 72 : Search Analysis for Clinical Trials Using Specific Keywords
Table 73 : Distribution of Clinical Trials on Biomarkers Based on Different Stages of Clinical Trials
Table 74 : Analysis of Biomarker Clinical Trials, Based on Sponsor
Table 75 : Examples of Clinical Trials Related to Biomarker R&D
Table 76 : Number of Clinical Trials Sponsored by Some Biomarker Market Participants
Table 77 : Number of Patents and Patent Applications Filed on Biomarkers, by Year, 2008-2017
Table 78 : Examples of Patents and Patent Applications Filed on Biomarkers, 2008-2017
Table 79 : Search Analysis for Patents and Patent Applications Using Keyword Combinations
Table 80 : Number of Patents and Patent Applications, by Company
Table 81 : Examples of Patents and Patent Applications Filed on Biomarkers, by Company
Table 82 : Global Value of Biomarkers Licensing, Acquisition and Partnership Deals, by Type, 2014-2018
Table 83 : Share of Biomarker Licensing Deals in Different Pathological Sectors, 2008-2018
Table 84 : Examples of Biomarker Market Participants and Total Number of Deals Related to Biomarker Activity
List of Figures
Summary Figure : Global Biomarkers Licensing, Acquisition and Partnership Deals Market, by Type, 2014-2018
Figure 1 : Schematic Presentation of Biomarker Development Process During Drug Development
Figure 2 : Global Biomarkers Market, 2016-2023
Figure 3 : Number of Biomarker Licensing Deals in Different Biotech Sectors, 2008-2018
Figure 4 : Share of Biomarker Licensing Deals in Different Biotech Sectors, by Year, 2008-2018
Figure 5 : Share of Biomarker Licensing Deals in Different Pathological Sectors, 2008-2018
Figure 6 : Purpose of Biomarker Licensing Deals, 2008-2018
Figure 7 : Share of Licensing Deals Between Companies and Academic Institutions vs. Between Two Companies, 2008-2018
Figure 8 : Share of Biomarker Licensing Deals in North America vs. Europe, 2008-2018
Figure 9 : Total Number of Biomarker Acquisition Deals in Different Biotech Sectors, 2008-2018
Figure 10 : Share of Biomarker Acquisition Deals in Different Biotech Sectors, by Year, 2008-2018
Figure 11 : Share of Biomarker Acquisition Deals in Different Pathological Sectors, 2008-2018
Figure 12 : Purpose of Biomarkers Acquisition Deals, 2008-2018
Figure 13 : Share of Biomarker Acquisition Deals in North America Vs. Europe, 2008-2018
Figure 14 : Total Number of Biomarker Collaboration Deals in Different Biotech Sectors, 2008-2018
Figure 15 : Share of Biomarker Collaboration Deals in Different Biotech Sectors, by Year, 2008-2018
Figure 16 : Share of Biomarker Collaboration Deals in Different Pathological Sectors, 2008-2018
Figure 17 : Purpose of Biomarkers Collaboration Deals, 2008-2018
Figure 18 : Share of Collaboration Deals Between Companies and Academic Institutions vs. Between Two Companies, 2008-2018
Figure 19 : Share of Biomarker Collaboration/Partnerships in North America vs. Europe, 2008-2018
Figure 20 : Global Biomarkers Licensing Deals Market, 2014-2018
Figure 21 : Global Biomarkers Acquisition Deals Market, 2014-2018
Figure 22 : Global Biomarkers Partnership Deals Market, 2014-2018
Figure 23 : Examples of Biomarker Market Participants and Total Number of Deals Related to Biomarker Activity, 2008-2018
Figure 24 : Number of Clinical Trials on Biomarkers Per Year, 2008-2017
Figure 25 : Search Analysis for Clinical Trials Using Specific Keywords
Figure 26 : Distribution of Clinical Trials on Biomarkers Based on Different Stages of Clinical Trials
Figure 27 : Number of Patents and Patent Applications Filed on Biomarkers, by Year, 2008-2017
Figure 28 : Search Analysis for Patents and Patent Applications Using Keyword Combinations
Figure 29 : Global Biomarkers Licensing, Acquisition and Partnership Deals Market, by Type, 2014-2018
Global Biomarkers Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Biomarkers market size was valued at US$ 61570 million in 2023. With growing demand in downstream market, the Biomarkers is forecast to a readjusted size of US$ 165240 million by 2030 with a CAGR of 15.1% during review period.
The research report highlights the growth potential of the global Biomarkers market. Biomarkers are expected to show stable growth in the future market. However, product differentiation, reducing costs,......
Global Biomarker (Medicine) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 114
Market Overview of Global Biomarker (Medicine) market:
According to our latest research, the global Biomarker (Medicine) market looks promising in the next 5 years. As of 2022, the global Biomarker (Medicine) market was estimated at USD 54332.95 million, and it's anticipated to reach USD 82760.29 million in 2028, with a CAGR of 7.27% during the forecast years.
Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker i......
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 131
According to our LPI (LP Information) latest study, the global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market size was valued at US$ 20920 million in 2023. With growing demand in downstream market, the Commercializing Biomarkers in Therapeutic and Diagnostic Applications is forecast to a readjusted size of US$ 29400 million by 2030 with a CAGR of 5.0% during review period.
The research report highlights the growth potential of the global Commercializing Biom......
Global Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 05-Dec-2023 Price: US 3380 Onwards Pages: 100
Market Overview of Global Biomarkers market:
According to our latest research, the global Biomarkers market looks promising in the next 5 years. As of 2022, the global Biomarkers market was estimated at USD 76755.97 million, and it's anticipated to reach USD 184776.75 million in 2028, with a CAGR of 15.77% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biomarkers market, with a......
Global Biomarker Technology Market Research Report 2023
Published: 01-Dec-2023 Price: US 2900 Onwards Pages: 86
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biomarker Technology market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Abbott Laboratories
- Quanterix
- Bio-Rad Laboratories
- Epigenomics
- Agilent Technologies
- Johnson & Johnson
- Qiagen
- Roche Ho......
Global Renal Biomarkers Market Research Report 2023
Published: 01-Dec-2023 Price: US 2900 Onwards Pages: 99
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Renal Biomarkers market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Abbott Diagnostics
- F. Hoffmann-La Roche
- Beckman Coulter
- Siemens Healthcare Diagnostics
- Thermo Fisher Scientific
- Astute Medical
- Bio......
Global Central Nervous System (CNS) Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 30-Nov-2023 Price: US 3380 Onwards Pages: 114
Market Overview of Global Central Nervous System (CNS) Biomarkers market:
According to our latest research, the global Central Nervous System (CNS) Biomarkers market looks promising in the next 5 years. As of 2022, the global Central Nervous System (CNS) Biomarkers market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
An overview of the global market for central nervous system (CNS) biomarke......
Global Cancer Biomarker Market Research Report 2023
Published: 13-Nov-2023 Price: US 2900 Onwards Pages: 109
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cancer Biomarker market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Roche Diagnostics
- Qiagen
- Illumina
- GE Healthcare
- Agilent Technologies
- Biomér......
Biomarker Collaboration and Licensing Deals 2016-2023
Published: 01-Nov-2023 Price: US 3995 Onwards Pages: 300
Biomarker Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the biomarker deals entered into by the worlds leading biopharma companies.
Fully revised and updated, the report provides details of biomarker deals from 2016 to 2023.
The report provides a detailed understanding and analysis of how and why companies enter biomarker deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercializ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
